Nanologica AB (publ)

Stockholm Stock Exchange NICA.ST

Nanologica AB (publ) Interest Coverage Ratio for the year ending December 31, 2023: -12.16

Nanologica AB (publ) Interest Coverage Ratio is -12.16 for the year ending December 31, 2023, a -21.26% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Nanologica AB (publ) Interest Coverage Ratio for the year ending December 31, 2022 was -10.03, a 22.03% change year over year.
Nanologica AB (publ) Interest Coverage Ratio for the year ending December 31, 2021 was -12.86, a -138.91% change year over year.
Nanologica AB (publ) Interest Coverage Ratio for the year ending December 31, 2020 was -5.38, a 80.13% change year over year.
Nanologica AB (publ) Interest Coverage Ratio for the year ending December 31, 2019 was -27.09, a -67.68% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Stockholm Stock Exchange: NICA.ST

Nanologica AB (publ)

CEO	Mr. Andreas Bhagwani
IPO Date	Oct. 30, 2015
Location	Sweden
Headquarters	Forskargatan 20G
Employees	16
Sector	Healthcare
Industries Biotechnology 3D Printing Chemicals & Advanced Materials Composite Materials Petrochemicals Pharmaceuticals Plastics Pollution Treatment

Description

Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.

Key trends

Past 5 years